G. A. Farago

904 total citations
13 papers, 694 citations indexed

About

G. A. Farago is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, G. A. Farago has authored 13 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in G. A. Farago's work include Cutaneous Melanoma Detection and Management (8 papers), Cutaneous lymphoproliferative disorders research (3 papers) and Immunotherapy and Immune Responses (2 papers). G. A. Farago is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), Cutaneous lymphoproliferative disorders research (3 papers) and Immunotherapy and Immune Responses (2 papers). G. A. Farago collaborates with scholars based in Australia and Canada. G. A. Farago's co-authors include H. M. Shaw, G. W. Milton, V. J. McGovern, William H. McCarthy, W. H. McCarthy, Pamela Dilworth, William R. Drucker, Henry Chan, R. E. Haist and Brenda L. Gallie and has published in prestigious journals such as Cancer, British journal of surgery and Advances in experimental medicine and biology.

In The Last Decade

G. A. Farago

13 papers receiving 633 citations

Peers

G. A. Farago
Christy Walker United Kingdom
Melanie Warycha United States
Clare Johnson United States
John W Kelly Australia
Andrea E. Dawson United States
Erica B. Friedman United States
Geoff Watson Australia
Christy Walker United Kingdom
G. A. Farago
Citations per year, relative to G. A. Farago G. A. Farago (= 1×) peers Christy Walker

Countries citing papers authored by G. A. Farago

Since Specialization
Citations

This map shows the geographic impact of G. A. Farago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. A. Farago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. A. Farago more than expected).

Fields of papers citing papers by G. A. Farago

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. A. Farago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. A. Farago. The network helps show where G. A. Farago may publish in the future.

Co-authorship network of co-authors of G. A. Farago

This figure shows the co-authorship network connecting the top 25 collaborators of G. A. Farago. A scholar is included among the top collaborators of G. A. Farago based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. A. Farago. G. A. Farago is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Shaw, H. M., V. J. McGovern, G. W. Milton, G. A. Farago, & William H. McCarthy. (1982). The female superiority in survival in clinical stage. II. Cutaneous malignant melanoma. Cancer. 49(9). 1941–1944. 26 indexed citations
2.
Shaw, H. M., V. J. McGovern, G. W. Milton, & G. A. Farago. (1981). CUTANEOUS MALIGNANT MELANOMA: OCCUPATION AND PROGNOSIS. The Medical Journal of Australia. 1(1). 37–38. 10 indexed citations
3.
Shaw, H. M., V. J. McGovern, G. W. Milton, G. A. Farago, & William H. McCarthy. (1980). Malignant melanoma: Influence of site of lesion and age of patient in the female superiority in survival. Cancer. 46(12). 2731–2735. 99 indexed citations
4.
Shaw, H. M., V. J. McGovern, G. W. Milton, G. A. Farago, & William H. McCarthy. (1980). Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer. 45(7). 1604–1608. 92 indexed citations
5.
Shaw, H. M., et al.. (1980). Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I). British journal of surgery. 67(8). 543–546. 59 indexed citations
6.
McGovern, V. J., H. M. Shaw, G. W. Milton, & G. A. Farago. (1980). Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity?. Histopathology. 4(3). 235–242. 110 indexed citations
7.
Shaw, H. M., G. W. Milton, William H. McCarthy, G. A. Farago, & Pamela Dilworth. (1979). Effect of Smoking on the Recurrence of Malignant Melanoma. The Medical Journal of Australia. 1(6). 208–209. 28 indexed citations
8.
McGovern, V. J., H. M. Shaw, G. W. Milton, & G. A. Farago. (1979). Prognostic significance of the histological features of malignant melanoma. Histopathology. 3(5). 385–393. 131 indexed citations
9.
Shaw, H. M., G. W. Milton, G. A. Farago, & W. H. McCarthy. (1978). Endocrine influences on survival from malignant melanoma. Cancer. 42(2). 669–677. 115 indexed citations
10.
Drucker, William R., et al.. (1973). The Effect of Persisting Hypovolemic Shock on Pancreatic Output of Insulin. Advances in experimental medicine and biology. 33(0). 187–198. 2 indexed citations
11.
Farago, G. A., et al.. (1972). PANCREATIC BLOOD FLOW AND INSULIN OUTPUT IN SEVERE HEMORRHAGE. The Journal of Trauma: Injury, Infection, and Critical Care. 12(10). 880–884. 18 indexed citations
12.
Farago, G. A., et al.. (1971). Pancreatic output of insulin in response to hemorrhagic shock.. PubMed. 22. 73–5. 2 indexed citations
13.
Farago, G. A., et al.. (1971). Availability of lipid for energy metabolism during hypovolemia.. PubMed. 22. 7–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026